Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
February 13-14, 2017 - New York, NY, USA
January 9-13 2017 - Los Angeles, LA, USA
November 29 and 30, 2016 - The Lotte New York Palace, New York - USA